Home » Newsletters » BioWorld Science

BioWorld Science

May 6, 2022

View Archived Issues

BCY-6033: EphA2-targeting BTC with efficacy in NSCLC PDX models

Enliven Therapeutics describes new Bcr-Abl kinase inhibitors

Silverback Therapeutics synthesizes TGFR-1 inhibitors and antibody-drug conjugates

CD38 inhibitors discovered at Napa Therapeutics, Buck Institute

Kymera Therapeutics presents STAT-degrading PROTACs

Vertex Pharmaceuticals patents CFTR modulators

Platform delivers siRNA targeting VEGF intravitreally for diabetic retinopathy

Turning Point and LaNova enter license agreement for LM-302 and collaboration on ADC programs

Insilico Medicine nominates preclinical candidate targeting MAT2A for MTAP-deleted cancers

Betta Pharmaceuticals presents preclinical results for cancer candidates BPI-371153 and BPI-442096

SPH-5030 demonstrates potent and selective activity in HER2-mutant cancer models

Orion enters agreement with Jemincare for Nav1.8 blocker for treatment of pain

Mosaic signs license agreement covering use of cowpea mosaic virus to treat cancer

Preclinical pipeline progress at Intellia Therapeutics

Clover reports neutralization findings from preclinical study of bivalent COVID-19 vaccine candidate

Taking aim at tumor metabolism, while taming toxicity

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...